Pilbara Minerals Limited (ASX: PLS) – Pilgangoora DFS results Boosting the Stock Price


Pilbara Minerals Limited (ASX: PLS) is witnessing a surge in stock price with encouraging update from Pilgangoora Lithium-Tantalum project. Financial outcomes at the Stage 2, 5Mtpa Pilgangoora Lithium-Tantalum project through the definitive feasibility study (DFS) were exceptional and the robust economics outlined a compelling case for the expansion to proceed following recent commissioning of the Stage 1, 2Mtpa facility. Post tax NPV of A$ 2.160 billion, LOM project revenue of $A 12.2 billion and LOM EBITDA of $A 6.3 billion has been highlighted. Approximately 800-850ktpa of average annual production of 6% spodumene concentrate and over estimated 17-year mine life and approximately 800,000lbs per annum of tantalite have been other highlights. The DFS has delivered a slight increase in capital costs from A$207M to A$231M.

[optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

This expansion of 5Mtpa Pilgangoora project, particularly through North Asia, will position Pilbara Minerals to meet the surging demand for lithium raw materials globally. The Pilbara stock traded at a market price of $0.902 (before market close at August 03, 2018) and has seen a daily price change of $0.057 or a percentage change of 6.75%. The performance change over the past 12 months has been 119.48%.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.


Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report